One-pot MCDA-CRISPR-Cas-based Detection Platform for Point-of-care Testing of Severe Acute Respiratory Syndrome Coronavirus 2

Overview

Journal Front Microbiol

Specialty Microbiology

Date 2024 Dec 23

PMID 39712894

Authors

Xiaoxia Wang

Rui Yang

Tian Tang

Yuzhen Zhou

Heng Chen

Yihao Jiang

Shirong Zhang

Sihan Qin

Meijuan Wang

Chuan Wang

Affiliations

Soon will be listed here.

Abstract

Compared to quantitative real-time PCR (q-PCR), CRISPR-Cas-mediated technology is more suitable for point-of-care testing (POCT) and has potential for wider application in the future. Generally, the operational procedure of CRISPR-Cas-mediated diagnostic method consists of two independent steps, the reaction of signal amplification and the CRISPR-Cas-mediated signal detection. Complex multi-step procedures can easily lead to cross-contamination. To develop a convenient and rapid method for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) detection, we propose a MCTOP method (ultiple cross displacement amplification-RISPR-Cas12b-based esting in ne-ot), which targets the open reading frame 1ab (ORF1ab) and nucleocapsid protein (N) gene of SARS-CoV-2. This method combines MCDA isothermal amplification and CRISPR-Cas-mediated sequence-specific detection into a one-pot reaction. The optimal reaction was achieved with isothermal amplification of 40 min and CRISPR-Cas-based detection of 15 min, both at 64°C. Then, the results can be visualized by the real-time fluorescence instrument and also lateral flow biosensor. The lowest detection limit of the proposed method is 10 copies of each of target sequences, and it has no cross-reactivity with non-SARS-CoV-2 templates. In a clinical test of 70 pharyngeal swab samples, MCTOP assay showed a specificity of 100% and sensitivities of 98 and 96% for the real-time fluorescence instrument and lateral flow biosensor, respectively. The MCTOP developed in this study is a rapid, convenient, highly sensitive, and specific method for SARS-CoV-2 nucleic acid detection. It can be used as an effective point-of-care testing (POCT) tool for clinical diagnosis and epidemiologic surveillance of SARS-CoV-2 infections, especially suitable for the basic, field and clinical laboratory.

References

Kaneko H, Kawana T, Fukushima E, Suzutani T . Tolerance of loop-mediated isothermal amplification to a culture medium and biological substances. J Biochem Biophys Methods. 2006; 70(3):499-501. DOI: 10.1016/j.jbbm.2006.08.008. View

Qiu X, Liu X, Wang R, Ma X, Han L, Yao J . Accurate, Sensitive, and Rapid Detection of Pseudomonas aeruginosa Based on CRISPR/Cas12b with One Fluid-Handling Step. Microbiol Spectr. 2023; 11(1):e0352322. PMC: 9927138. DOI: 10.1128/spectrum.03523-22. View

Li L, Li S, Wu N, Wu J, Wang G, Zhao G . HOLMESv2: A CRISPR-Cas12b-Assisted Platform for Nucleic Acid Detection and DNA Methylation Quantitation. ACS Synth Biol. 2019; 8(10):2228-2237. DOI: 10.1021/acssynbio.9b00209. View

Broughton J, Deng X, Yu G, Fasching C, Servellita V, Singh J . CRISPR-Cas12-based detection of SARS-CoV-2. Nat Biotechnol. 2020; 38(7):870-874. PMC: 9107629. DOI: 10.1038/s41587-020-0513-4. View

Drain P . Rapid Diagnostic Testing for SARS-CoV-2. N Engl J Med. 2022; 386(3):264-272. PMC: 8820190. DOI: 10.1056/NEJMcp2117115. View

Sugiharto V, Gatrell S, Chen H, Blazek G, Cherry A, Schilling M . Performance Evaluation of Five Rapid At-Home COVID-19 Antigen Tests against the Omicron Variant. Microbiol Spectr. 2022; 11(1):e0228622. PMC: 9927253. DOI: 10.1128/spectrum.02286-22. View

Wang Y, Luu L, Liu S, Zhu X, Huang S, Li F . Single-cell transcriptomic analysis reveals a systemic immune dysregulation in COVID-19-associated pediatric encephalopathy. Signal Transduct Target Ther. 2023; 8(1):398. PMC: 10582072. DOI: 10.1038/s41392-023-01641-y. View

Chertow D . Next-generation diagnostics with CRISPR. Science. 2018; 360(6387):381-382. DOI: 10.1126/science.aat4982. View

Chen Y, Xu X, Wang J, Zhang Y, Zeng W, Liu Y . Photoactivatable CRISPR/Cas12a Strategy for One-Pot DETECTR Molecular Diagnosis. Anal Chem. 2022; 94(27):9724-9731. DOI: 10.1021/acs.analchem.2c01193. View

10.

Viloria Winnett A, Akana R, Shelby N, Davich H, Caldera S, Yamada T . Daily SARS-CoV-2 Nasal Antigen Tests Miss Infected and Presumably Infectious People Due to Viral Load Differences among Specimen Types. Microbiol Spectr. 2023; 11(4):e0129523. PMC: 10434058. DOI: 10.1128/spectrum.01295-23. View

11.

Chen Y, Shi Y, Chen Y, Yang Z, Wu H, Zhou Z . Contamination-free visual detection of SARS-CoV-2 with CRISPR/Cas12a: A promising method in the point-of-care detection. Biosens Bioelectron. 2020; 169:112642. PMC: 7502227. DOI: 10.1016/j.bios.2020.112642. View

12.

Rahbari R, Moradi N, Abdi M . rRT-PCR for SARS-CoV-2: Analytical considerations. Clin Chim Acta. 2021; 516:1-7. PMC: 7826022. DOI: 10.1016/j.cca.2021.01.011. View

13.

Florkowski C . Sensitivity, specificity, receiver-operating characteristic (ROC) curves and likelihood ratios: communicating the performance of diagnostic tests. Clin Biochem Rev. 2008; 29 Suppl 1:S83-7. PMC: 2556590. View

14.

Gootenberg J, Abudayyeh O, Lee J, Essletzbichler P, Dy A, Joung J . Nucleic acid detection with CRISPR-Cas13a/C2c2. Science. 2017; 356(6336):438-442. PMC: 5526198. DOI: 10.1126/science.aam9321. View

15.

Zhu X, Wang X, Li S, Luo W, Zhang X, Wang C . Rapid, Ultrasensitive, and Highly Specific Diagnosis of COVID-19 by CRISPR-Based Detection. ACS Sens. 2021; 6(3):881-888. DOI: 10.1021/acssensors.0c01984. View

16.

Guo L, Sun X, Wang X, Liang C, Jiang H, Gao Q . SARS-CoV-2 detection with CRISPR diagnostics. Cell Discov. 2020; 6:34. PMC: 7235268. DOI: 10.1038/s41421-020-0174-y. View

17.

Li S, Cheng Q, Liu J, Nie X, Zhao G, Wang J . CRISPR-Cas12a has both cis- and trans-cleavage activities on single-stranded DNA. Cell Res. 2018; 28(4):491-493. PMC: 5939048. DOI: 10.1038/s41422-018-0022-x. View

18.

Li S, Huang J, Ren L, Jiang W, Wang M, Zhuang L . A one-step, one-pot CRISPR nucleic acid detection platform (CRISPR-top): Application for the diagnosis of COVID-19. Talanta. 2021; 233:122591. PMC: 8197615. DOI: 10.1016/j.talanta.2021.122591. View

19.

Won J, Lee S, Park M, Kim T, Park M, Choi B . Development of a Laboratory-safe and Low-cost Detection Protocol for SARS-CoV-2 of the Coronavirus Disease 2019 (COVID-19). Exp Neurobiol. 2020; 29(2):107-119. PMC: 7237269. DOI: 10.5607/en20009. View

20.

Ding X, Yin K, Li Z, Lalla R, Ballesteros E, Sfeir M . Ultrasensitive and visual detection of SARS-CoV-2 using all-in-one dual CRISPR-Cas12a assay. Nat Commun. 2020; 11(1):4711. PMC: 7501862. DOI: 10.1038/s41467-020-18575-6. View